Nancy Ham Sells 1,172 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) Director Nancy Ham sold 1,172 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the transaction, the director now directly owns 1,112 shares in the company, valued at $107,552.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

U.S. Physical Therapy Stock Down 0.2 %

USPH stock opened at $91.87 on Thursday. The company has a quick ratio of 1.88, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The stock has a market capitalization of $1.39 billion, a PE ratio of 97.73, a price-to-earnings-growth ratio of 4.16 and a beta of 1.38. The firm has a 50 day moving average of $84.02 and a 200 day moving average of $91.26.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. During the same period in the previous year, the company earned $0.76 earnings per share. U.S. Physical Therapy’s revenue was up 10.4% on a year-over-year basis. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 1.92%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy’s payout ratio is 187.23%.

Wall Street Analyst Weigh In

USPH has been the subject of several research reports. Bank of America reaffirmed a “neutral” rating and issued a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Barrington Research reiterated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 7th. Finally, StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in USPH. Silvercrest Asset Management Group LLC acquired a new position in U.S. Physical Therapy in the first quarter valued at approximately $8,158,000. Renaissance Technologies LLC raised its position in shares of U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock worth $6,425,000 after purchasing an additional 61,474 shares during the last quarter. Penn Davis Mcfarland Inc. purchased a new stake in U.S. Physical Therapy during the 3rd quarter worth approximately $2,552,000. BNP Paribas Financial Markets boosted its stake in U.S. Physical Therapy by 283.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after purchasing an additional 12,445 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in U.S. Physical Therapy by 2.5% during the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock worth $39,173,000 after buying an additional 10,462 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.